Showing results (291-300 of 322) with videos related to
Sort By:
Pageof 33
The Journal of Urology|July 1, 1990
Outcome of renal transplantation in patients with a functioning graft for 20 years or moreS A Slavis, A C Novick, D R Steinmuller, et al.Urology|June 1, 1986
Comparison of renal transplantation and dialysis in rehabilitation of diabetic end-stage renal disease patientsR B Khauli, A C Novick, D R Steinmuller, et al.Urological Research|January 11, 1991
Improved renal transplant preservation using a modified intracellular flush solution (PB-2). Characterization of mechanisms by renal clearance, high performance liquid chromatography, phosphorus-31 magnetic resonance spectroscopy, and electron microscopy studiesP N Bretan, N Baldwin, A Martinez, et al.Urological Research|January 1, 1997
Molecular regulation of intercellular adhesion molecule 1 (ICAM-1) expression in renal cell carcinomaK Tanabe, S C Campbell, J P Alexander, et al.Urological Research|January 1, 1995
Expression of cell adhesion molecules in an established and characterized new human renal cell cancer line, CCF-RC7F Steinbach, J Alexander, K Tanabe, et al.Cancer|December 18, 2001
Laparoscopic radical nephrectomy in 100 patients: a single center experience from the United StatesI S Gill, A M Meraney, D K Schweizer, et al.Transplantation|October 1, 1993
Fate of renal allografts transplanted in patients with urinary diversionD A Hatch, P Belitsky, J M Barry, et al.Transplantation|November 26, 1999
Quantitative assessment of the first acute rejection as a predictor of renal transplant outcomeA Ishikawa, S M Flechner, D A Goldfarb, et al.The Journal of Urology|November 1, 1990
Magnetic resonance imaging for assessment of vena caval tumor thrombi: a comparative study with venacavography and computerized tomography scanningD A Goldfarb, A C Novick, R Lorig, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 24, 1999
Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinomaR A Figlin, J A Thompson, R M Bukowski, et al.Pageof 33